ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $99,000 | -27.7% | 2,804 | -6.0% | 0.03% | +3.6% |
Q1 2022 | $137,000 | -31.2% | 2,983 | -0.7% | 0.03% | -28.2% |
Q4 2021 | $199,000 | +5.3% | 3,003 | -0.7% | 0.04% | -7.1% |
Q3 2021 | $189,000 | +2.7% | 3,023 | +0.6% | 0.04% | +5.0% |
Q2 2021 | $184,000 | -8.5% | 3,005 | -1.1% | 0.04% | -14.9% |
Q1 2021 | $201,000 | -31.6% | 3,038 | -20.7% | 0.05% | -29.9% |
Q4 2020 | $294,000 | -5.8% | 3,829 | -64.8% | 0.07% | -44.2% |
Q1 2020 | $312,000 | -55.1% | 10,868 | -0.8% | 0.12% | -40.9% |
Q4 2019 | $695,000 | +499.1% | 10,955 | +167.0% | 0.20% | +383.3% |
Q3 2019 | $116,000 | -1.7% | 4,103 | -7.9% | 0.04% | +13.5% |
Q2 2019 | $118,000 | – | 4,456 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |